0.011621 USD
10.85 M USD
554.83 M USD
328.64 M
About Novolog (Pharm UP 1966) Ltd.
Sector
Industry
CEO
Eran Taus
Website
Headquarters
Modi'in-Maccabim-Re'ut
Founded
1966
ISIN
IL0011401515
FIGI
BBG01W91MY07
Novolog (Pharm UP 1966) Ltd. engages in the provision of healthcare services. The firm also operates and markets two digital platforms for physicians and clinics, which are scheduling appointments and managing diaries and telemedicine sessions. It operates through the following segments: Logistics, Health Services, and Digital. The Logistics segment includes drugs and medical products distribution services, logistics of clinical trials, provision of pharmaceutical services to clients and sterilization of perishable medical equipment. The Health Services segment provides services to patients, health organizations, insurance companies, and multinational companies. The Digital segment makes medical information accessible to the general public through medical websites, and promotes digital presence for clinics, doctors, and medical entities through digital means. The company was founded on August 25, 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NOVOLOG PHARM UP 1966 LTD. stocks are traded under the ticker NVLGF.
Yes, you can track NOVOLOG PHARM UP 1966 LTD. financials in yearly and quarterly reports right on TradingView.
NVLGF net income for the last quarter is 1.41 M USD, while the quarter before that showed 271.57 K USD of net income which accounts for 420.24% change. Track more NOVOLOG PHARM UP 1966 LTD. financial stats to get the full picture.
As of Sep 30, 2025, the company has 936 employees. See our rating of the largest employees — is NOVOLOG PHARM UP 1966 LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVOLOG PHARM UP 1966 LTD. EBITDA is 35.70 M USD, and current EBITDA margin is 6.83%. See more stats in NOVOLOG PHARM UP 1966 LTD. financial statements.
Like other stocks, NVLGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOLOG PHARM UP 1966 LTD. stock right from TradingView charts — choose your broker and connect to your account.